title: Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
authors.forename: Federico
authors.initials: F
authors.lastname: Pea
authors.forename: Piergiorgio
authors.initials: P
authors.lastname: Cojutti
authors.forename: Nicola
authors.initials: N
authors.lastname: Petrosillo
authors.forename: Mario
authors.initials: M
authors.lastname: Furlanut
authors.forename: J M
authors.initials: JM
authors.lastname: Entenza
authors.forename: T R
authors.initials: TR
authors.lastname: Veloso
authors.forename: J
authors.initials: J
authors.lastname: Vouillamoz
authors.forename: M
authors.initials: M
authors.lastname: Giddey
authors.forename: P
authors.initials: P
authors.lastname: Moreillon
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D004696:Endocarditis / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000472:pathogenicity*; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin